interleukin 2 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
96
Structured Review
R&D Systems
interleukin 2
Interleukin 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 911 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+interleukin+2/Recombinant+Human+IL-2+Protein/pmc13103101-272-19-23
Average 96 stars, based on 911 article reviews
Interleukin 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 911 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+interleukin+2/Recombinant+Human+IL-2+Protein/pmc13103101-272-19-23
Average 96 stars, based on 911 article reviews
interleukin 2 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Recombinant:Article Title: Methods of using anti-PSGL-1 antibodies in combination with JAK inhibitors to treat T-cell mediated inflammatory diseases or cancers Article Snippet: Isolation was performed by density centrifugation of blood on Ficoll (GE Healthcare, Cat #17-1440-03). .. The harvested PBMCs were used for the generation of activated T cells by incubating with PHA (3 μg/mL, SIGMA, Cat: L2769-10 mg) in RPMI-1640 medium (10% FBS, 1% Penicillin/Streptomycin and 2-Mercaptoethanol) for 2 days, followed by maintenance in medium containing recombinant Article Title: Cancer vaccine overcomes immune evasion of nasopharyngeal carcinoma by restoring MHC-I through transcriptional regulation of NLRC5. Article Snippet: .. CD8+ T cells were supplemented with 50 IU/mL of recombinant Article Title: Cancer vaccine overcomes immune evasion of nasopharyngeal carcinoma by restoring MHC-I through transcriptional regulation of NLRC5 Article Snippet: .. CD8 + T cells were supplemented with 50 IU/mL of recombinant Article Title: Inhibiting mTORC1 pathway by rapamycin restores the balance of CD8 + T cell subsets and reduces CD8 + T cell-mediated platelet destruction in immune thrombocytopenia. Article Snippet: Background: CD8 T cells contribute to platelet destruction in immune thrombocytopenia (ITP).. Rapamycin, a mechanistic target of rapamycin complex 1 (mTORC1) inhibitor, has demonstrated efficacy in relapsed/refractory ITP.. However, its impact on CD8 T cells in ITP remains unexplored. Article Title: Methods of using anti-PSGL-1 antibodies in combination with JAK inhibitors to treat T-cell mediated inflammatory diseases or cancers Article Snippet: .. The harvested PBMCs were used for the generation of activated T cells by incubating with PHA (3 μg/mL, SIGMA, Cat: L2769-10 mg) in RPMI-1640 medium containing 10% fetal bovine serum (FBS) for 2 days, followed by maintenance in medium containing recombinant Isolation:Article Title: Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical Human Pancreatic Cancer Mouse Model Article Snippet: Cells were counted within the Leica LasX software within the region of interest corresponding to the image gathered using the ×10 objective. .. Human T cells were isolated from the peripheral blood mononuclear cells of a healthy donor using Human CD3+ T cell Isolation Kit (STEMCELL, no. 17751) and activated using αCD3/CD28 Dynabeads (Thermo Fisher, no. 11132D) and 200 U/ml Cell Isolation:Article Title: Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical Human Pancreatic Cancer Mouse Model Article Snippet: Cells were counted within the Leica LasX software within the region of interest corresponding to the image gathered using the ×10 objective. .. Human T cells were isolated from the peripheral blood mononuclear cells of a healthy donor using Human CD3+ T cell Isolation Kit (STEMCELL, no. 17751) and activated using αCD3/CD28 Dynabeads (Thermo Fisher, no. 11132D) and 200 U/ml Activation Assay:Article Title: Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical Human Pancreatic Cancer Mouse Model Article Snippet: Cells were counted within the Leica LasX software within the region of interest corresponding to the image gathered using the ×10 objective. .. Human T cells were isolated from the peripheral blood mononuclear cells of a healthy donor using Human CD3+ T cell Isolation Kit (STEMCELL, no. 17751) and activated using αCD3/CD28 Dynabeads (Thermo Fisher, no. 11132D) and 200 U/ml Transduction:Article Title: Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical Human Pancreatic Cancer Mouse Model Article Snippet: Cells were counted within the Leica LasX software within the region of interest corresponding to the image gathered using the ×10 objective. .. Human T cells were isolated from the peripheral blood mononuclear cells of a healthy donor using Human CD3+ T cell Isolation Kit (STEMCELL, no. 17751) and activated using αCD3/CD28 Dynabeads (Thermo Fisher, no. 11132D) and 200 U/ml Centrifugation:Article Title: Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical Human Pancreatic Cancer Mouse Model Article Snippet: Cells were counted within the Leica LasX software within the region of interest corresponding to the image gathered using the ×10 objective. .. Human T cells were isolated from the peripheral blood mononuclear cells of a healthy donor using Human CD3+ T cell Isolation Kit (STEMCELL, no. 17751) and activated using αCD3/CD28 Dynabeads (Thermo Fisher, no. 11132D) and 200 U/ml |